Huibers, C. J. A. http://orcid.org/0000-0002-2861-0068
Sallevelt, B. T. G. M.
Heij, J. M. J. op
O’Mahony, D.
Rodondi, N.
Dalleur, O.
van Marum, R. J.
Egberts, A. C. G.
Wilting, I.
Knol, W.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial
https://doi.org/10.1007/s40266-023-01029-1
Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity
https://doi.org/10.1007/s40266-021-00904-z
Rationale and design of OPtimising thERapy to prevent Avoidable hospital
admissions in Multimorbid older people (OPERAM): a cluster randomised
controlled trial
https://doi.org/10.1136/bmjopen-2018-026769
Hospital physicians’ and older patients’ agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting
https://doi.org/10.1007/s41999-022-00633-5
Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
https://doi.org/10.1136/bmj.n1585
Funding for this research was provided by:
Horizon 2020
Article History
Received: 30 September 2021
Accepted: 18 February 2022
First Online: 15 March 2022
Declarations
:
: D. O’Mahony has a patent: a Prescription Decision Support System (based on screening tool of older person’s prescriptions and screening tool to alert to the right treatment (STOPP/START) prescribing rules) issued to European Patent Office (Munich). None of the other authors have a potential conflict of interest to disclose.
: The local ethics committee at each participating trial site approved the OPERAM study protocol. Written informed consent was obtained from the patients or their legal representatives before enrolment in the OPERAM trial. The OPERAM trial was approved by the independent research ethics committees at each participating site (lead ethics committee: Cantonal Ethics Committee Bern, Switzerland, ID 2016-01200; Medical Research Ethics Committee Utrecht, Netherlands, ID 15-522/D; Comité d’Ethique Hospitalo-Facultaire Saint-Luc-UCL: 2016/20JUL/347– Belgian registration No: B403201629175; Cork University Teaching Hospitals Clinical Ethics Committee, Cork, Republic of Ireland; ID ECM 4 (o) 07/02/17), and Swissmedic as a responsible regulatory authority.
: Not applicable.
: Not applicable.
: Written informed consent was obtained from the patients or their legal representatives before enrolment in the OPERAM trial.